Advertisement
Advertisement

DTIL

DTIL logo

Precision Biosciences Inc

4.16
USD
-0.42
-9.17%
Dec 18, 15:59 UTC -5
Closed
...

Precision Biosciences Inc Profile

About

Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

Info & Links

CEO

Michael Amoroso

Headquarters

302 EAST PETTIGREW STREET,SUITE A-100
DURHAM, NC 27701, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

25

Employees

109

Precision Biosciences Inc Statistics

Valuation Measures

Market Capitalization2

31.91M

Enterprise Value

-44.57M

Enterprise Value/EBITDA(ttm)

3.86

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.56

Price to Book(mrq)

0.61

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-15.43%

Profit Margin(ttm)

-742.13%

Return on Equity(ttm)

-23.69%

Return on Invested Capital(ttm)

-23.16%

Return on Assets(ttm)

-6.98%

Income Statement

Revenue(ttm)

75.10M

Revenue Per Share(ttm)

9.79

Gross Profit(ttm)

75.10M

EBITDA(ttm)3

-11.54M

Net Income Available to Common(ttm)

8.62M

Diluted EPS(ttm)

0.06

Share Statistics

Beta (5Y Monthly)

1.41

52-Week Change

-64.09%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

7.67M

Dividend Yield

0.00%

Float4

7.36M

% Held by Insiders

4.00%

% Held by Institutions

37.99%

Balance Sheet

Total Cash(mrq)

101.20M

Total Cash Per Share(mrq)

13.19

Total Debt(mrq)

22.28M

Total Debt/Equity(mrq)

34.34%

Current Ratio(mrq)

9.22%

Quick Ratio(mrq)

9.22%

Book Value Per Share(mrq)

8.67

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.46

Free Cash Flow(ytd)

-39.85M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement